Summary
Factor VIII-related antigen and von Willebrand factor are synthesised by and released from vascular endothelium. Acute increases in the plasma concentration of these proteins may reflect endothelial cell damage. We have thus measured the plasma concentration of factor VIII-related antigen and von Willebrand factor, together with procoagulant factor VIII, during the course of acute diabetic ketoacidosis in seven patients. In addition, evidence for qualitative changes in the factor VIII complex was sought. Plasma factor VIII-related antigen and von Willebrand factor were markedly increased (plasma factor VIII-related antigen at presentation, median 2.75 U/ml; von Willebrand factor 2.95 U/ml) and returned toward normal with clinical and biochemical resolution (plasma factor VIII-related antigen at clinical recovery, median 1.80 U/ml; von Willebrand factor 2.05 U/ml). Plasma procoagulant factor VIII followed a similar pattern, but levels were less elevated (plasma procoagulant factor VIII, at presentation, median 1.6U/ml; at clinical recovery, 1.2U/ml). Crossed immunoelectrophoresis and sodium dodecyl sulphate-acrylamide electrophoresis with autoradiographic identification of multimeric structure revealed no evidence of structurally abnormal factor VIII-related antigen in diabetic ketoacidosis. However, an extra peak on crossed immunoelectrophoresis (“pre-peak”) was a feature in the acute phase ketoacidotic plasma in six subjects, and may represent aggregated factor VIII. Changes in plasma factor VIII are a feature of diabetic ketoacidosis and, whilst not specific to this condition, may be the result of endothelial cell damage.
Article PDF
Similar content being viewed by others
References
Bensoussan D, Levy-Toledano S, Passa P, Caen J, Canivet J (1975) Platelet hyperaggregation and increased plasma levels of von Willebrand factor in diabetics with retinopathy. Diabetologia 11: 307–312
Borkenstein MH, Muntean WE (1982) Elevated factor VIII activity and factor VIII-related antigen in diabetic children without vascular disease. Diabetes 31: 1006–1009
Brooks AMV, Hussein S, Chesterman CN, Martin JF, Alford FP, Penington DG (1983) Platelets, coagulation and fibrinolysis in patients with diabetic retinopathy. Thromb Haemost 49: 123–127
Coller BS, Frank RN, Milton RC, Gralnick HR (1978) Plasma co-factors of platelet function: correlation with diabetic retinopathy and hemoglobins A1a–c. Ann Int Med 88: 311–316
Fuller JH, Keen H, Jarret RJ, Omer T, Meade TW, Chakrabarti R, North WRS, Stirling Y (1979) Haemostatic variables associated with diabetes and its complications. Br Med J 2: 964–966
Gensini GF, Abbate R, Favilla S, Neri Serneri GG (1979) Changes of platelet function and blood clotting in diabetes mellitus. Thromb Haemost 42: 983–993
Gonzalez J, Colwell JA, Sarji KE, Nair RMG, Sagel J (1980) Effect of metabolic control with insulin on plasma von Willebrand factor activity (VIII R/vWF) in diabetes mellitus. Thromb Res 17: 261–266
Lufkin EG, Fass DN, O'Fallon WM, Bowie EJW (1979) Increased von Willebrand factor in diabetes mellitus. Metabolism 28: 63–66
Odegaard AE, Skalhegg BA, Hellen AJ (1964) Increased activity of “anti-Willebrand factor” in diabetic plasma. Thromb Diath Haemorrh 11: 27–37
Pandolfi M, Almir LO, Holmberg L (1974) Increased von Willebrand antihemophilic factor A in diabetic retinopathy. Acta Ophthalmol 52: 823–828
Porta M, Townsend C, Clover GM, Nanson M, Alderson AR, McCraw A, Kohner EM (1981) Evidence for functional endothelial cell damage in early diabetic retinopathy. Diabetologia 20: 597–601
Rak K, Beck P, Udvardy M, Pfliegler G, Misz M, Boda Z (1983) Plasma levels of beta-thromboglobulin and factor VIII-related antigen in diabetic children and adults. Thromb Res 29: 155–162
van Oost BA, Veldhuyzen BFC, van Houwelingen HC, Timmermans APM, Sixma JJ (1982) Tests for platelet changes, acute phase reactants and serum lipids in diabetes mellitus and peripheral vascular disease. Thromb Haemost 48: 289–293
Boneu B, Abbal M, Plante J, Bierme R (1975) Factor-VIII complex and endothelial damage. Lancet 1: 1430
Grant K, Rodvien R, Mielke CH (1978) Altered factor VIII complexes in patients with acute respiratory insufficiency. Thromb Haemost 40: 326–334
Carvalho ACA, Bellman SM, Saullo VJ, Quinn D, Zapol WM (1982) Altered factor VIII in acute respiratory failure. N Engl J Med 307: 1113–1119
Biggs R, Eveling J, Richards G (1955) The assay of antihaemophilic globulin activity. Br J Haematol 1: 20–24
Evans RJ, Austen DEG (1977) Assay of ristocetin co-factor using fixed platelets and a platelet counting technique. Br J Haematol 37: 289–294
Laurell CB (1965) Antigen-antibody crossed electrophoresis. Ann Biochem 10: 358–361
Short PE, Williams CE, Picken AM, Mill FGH (1982) Factor VIII related antigen: an improved enzyme immunoassay. Med Lab Sci 39: 351–355
Reay P (1982) Use of N-bromosuccinimide for the iodination of proteins for radioimmunoassay. Ann Clin Biochem 19: 129–133
Ball J, Malia RG, Greaves M, Preston FE (1986) Demonstration of abnormal factor VIII multimers in acquired von Willebrand's disease associated with a circulating inhibitor. Br J Haematol (in press)
Ruggeri ZM, Zimmerman TS (1980) The complex multimeric composition of factor VIII/von Willebrand factor. Blood 57: 1140–1143
Enayat MS, Hill FGH (1983) Analysis of the complexity of the multimeric structure of factor VIII related antigen/von Willebrand protein using a modified electrophoretic technique. J Clin Pathol 36: 915–919
Paton RC (1981) Haemostatic changes in diabetic coma. Diabetologia 21: 172–177
Brozovic M (1977) Physiological mechanisms in coagulation and fibrinolysis. Br Med Bull 33: 231–236
Giustolisi R, Musso R, Russo M, Catania N, Lombarde T, Cacciola E (1982) Possible evidence for an increased factor VIII antigen synthesis in vascular endothelium of diabetic subjects. Thromb Haemost 47: 293
Timperley WR, Preston FE, Ward JD (1974) Cerebral intravascular coagulation in diabetic ketoacidosis. Lancet 1: 952–956
Muntean WE, Borkenstein MH, Haas J (1985) Elevation of factor VIII coagulant activity over factor VIII coagulant antigen in diabetic children without vascular disease. A sign of activation of the factor VIII coagulant moiety during poor diabetes control. Diabetes 34: 140–144
Bowie EJW, Fass DN (1979) Factor VIII-related antigen (VIII RAg) in haemophilic patients and in carriers. Lancet 2: 1049–1050
Miller CH, Hilgartner MW, LeStrange RC, McLaughlin GW (1982) Factor VIII-related antigen pre-peak on crossed immunoelectrophoresis: A non-random phenomenon. Thromb Res 25: 101–107
Girolami A, Sticchi A, Cappellato G, Quaino V (1980) Factor VIII antigen pre-peak. Lancet 1: 264–265
Howard MA, Perkin J, Koutts J (1980) Factor VIII antigen pre-peak. Lancet 1: 715
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Greaves, M., Pickering, C., Knight, G. et al. Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage?. Diabetologia 30, 160–165 (1987). https://doi.org/10.1007/BF00274221
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00274221